Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Disease area: Pulmonary vascular diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Günther, M. C. Chaumais, P. Dorfmüller, X. Jaïs, L. Savale, E. Artaud-Macari, F. Perros, S. Cohen-Kaminsky, O. Sitbon, M. Humbert, G. Simmoneau, D. Montani (Le Kremlin Bicêtre, Le Plessis Robinson, France). Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review. Eur Respir J 2013; 42: Suppl. 57, 2635

Member's Comments

No comment yet.

Related content which might interest you: Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Does Wells score documentation really prevent excessive CTPA requests in a teaching hospital? A retrospective study in 800 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 CPFE (combined pulmonary fibrosis and emphysema): A case series Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Source: Eur Respir J 2012; 39: 945-955 Year: 2012 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010 Measurement of small pulmonary vessels by using computed tomography (CT) in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014